Hannah Berntsson

BSc MSc

School of Medicine and Population Health

Study Manager/Quality Assurance Manager

h.berntsson@sheffield.ac.uk
+44 114 222 8278

Room 2.04a, The Innovation Centre

Full contact details

Hannah Berntsson
School of Medicine and Population Health
Room 2.04a
The Innovation Centre
217 Portobello
Sheffield
S1 4DP

Profile

I joined the Clinical Trials Research Unit in January 2020 as a Research Assistant working on the ASTIClite Trial, which is a CTIMP investigating the efficacy of autologous haematopoietic stem cell transplantation for Crohn’s disease.

Prior to joining the CTRU I worked for Sheffield Teaching Hospitals department of Neuroscience as a research administrator, supporting trials across a range of conditions within neurology. I have a BSc in Psychology from City University London and an MSc in Translational Neuroscience from the University of Sheffield.

Qualifications

BSc Psychology

MSc Translational Neuroscience

Publications

Show: Featured publications All publications

Featured publications

This person does not have any publications available.

All publications

Journal articles

Lindsay JO, Hind D, Swaby L, Berntsson H, Bradburn M, Bannur C U, Byrne J, Clarke C, Desoysa L, Din S , Emsley R et al (2024) Autologous stem cell transplantation with low-dose cyclophosphamide to improve mucosal healing in adults with refractory Crohn’s disease: the ASTIClite RCT. Efficacy and Mechanism Evaluation, 11(3). View this article in WRRO
Berntsson H, Thien A, Hind D, Stewart L, Mahzabin M, Tung WS, Bradburn M & Kurien M (2024) Interventions for Managing Late Gastrointestinal Symptoms Following Pelvic Radiotherapy: a Systematic Review and Meta-analysis. Clinical Oncology.
Lindsay JO, Hind D, Swaby E, Berntsson H, Bradburn M, Bannur U, Byrne J, Clarke C, Desoysa L, Dickins B , Din S et al (2024) Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn’s disease (ASTIClite): an open-label, multicentre, randomised controlled trial. The Lancet Gastroenterology and Hepatology. View this article in WRRO
Boxell EG, Malik Y, Wong J, Lee MH, Berntsson HM, Lee MJ, Bourne RS, McCullagh IJ, Hind D & Wilson MJ (2021) Are treatment effects consistent with hypothesized mechanisms of action proposed for postoperative delirium interventions? Reanalysis of systematic reviews. Journal of Comparative Effectiveness Research. View this article in WRRO
Bamford E, Berntsson H, Beale S, Desoysa L, Dias J, Hamer-Kiwacz S, Hind D, Johnson N, Loban A, Molloy K , Morvan E et al () Flexor Injury Rehabilitation Splint Trial (FIRST): protocol for a pragmatic randomised controlled trial comparing three splints for finger flexor tendon repairs. Trials, 25(1).
Bursnall M, Thomas B, Berntsson H, Strong E, Hind D & Brayne M () Clinician and Patient Experience of Internet-Mediated Eye Movement Desensitisation and Reprocessing Therapy. Journal of Psychosocial Rehabilitation and Mental Health. View this article in WRRO

Preprints

Bamford E, Berntsson H, Beale S, Desoysa L, Dias J, Hamer-Kiwacz S, Hind D, Johnson N, Loban A, Molloy K , Morvan E et al (2024) Flexor Injury Rehabilitation Splint Trial (FIRST): Protocol for a pragmatic randomised controlled trial comparing three splints for finger flexor tendon repairs, Research Square Platform LLC.
Scott AJ, Flowers O, Sheldon E, Berntsson H & Rowse G () Perceptions of sleep in Inflammatory Bowel Disease and the acceptability of sleep interventions in routine care: A qualitative study, Center for Open Science.